Filing Details
- Accession Number:
- 0001179929-15-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-05 18:56:11
- Reporting Period:
- 2015-03-05
- Filing Date:
- 2015-03-05
- Accepted Time:
- 2015-03-05 18:56:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1179929 | Molina Healthcare Inc | MOH | Hospital & Medical Service Plans (6324) | 134204626 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1305822 | Terry Bayer | 300 University Avenue, Suite 100 Sacramento CA 95825 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-03-05 | 7,446 | $61.85 | 104,060 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | $19.11 | 2016-02-02 | 21,000 | 21,000 | Direct | |
Common Stock | Stock Options (Right to Buy) | $20.88 | 2017-03-01 | 16,500 | 16,500 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2016-02-02 | 21,000 | 21,000 | Direct |
2017-03-01 | 16,500 | 16,500 | Direct |
Footnotes
- The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on September 15, 2014.
- Represents the weighted average selling price with a selling price range between $61.54 and $62.21.
- The shares vest as follows: (i) 15,572 shares shall vest upon the Company achieving total revenue in any of the 2013, 2014, or 2015 fiscal years equal to or greater than $12 billion; (ii) 4,644 shares shall vest upon the Company achieving three-year Total Stockholder Return (TSR) as determined by ISS calculations that is greater than the median TSR achieved by the Company's ISS peer group for the three-year period ending December 31, 2016; continued
- (iii) 11,611 shares shall vest upon the Company achieving a three-year EBITDA margin percentage for the three-year period ending December 31, 2016 equal to or greater than 4.0%; (iv) 11,611 of shares shall vest upon the Company achieving a cumulative earnings per share of at least $8.50 for the three year period ending December 31, 2016; continued
- (v) 9,836 shares vest on March 1, 2016; and (vi) 4,644 shares vest on March 1, 2017. The remainder of the shares are vested.
- The options are fully vested.